|
⚲
|
| Keyboard |
| Title 19 Promis
✚
|
|
|---|---|
| CIK # | 0002005531 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002005531] | |
| 4 | [0002005531] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Title 19 Promis | |
| Amorfix Life Sciences Ltd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Amorfix Life Sciences Ltd PMN
Warrants to Purchase Common Shares · derivative
|
2025-07-29 | Buy | 539,100 | ||
|
Amorfix Life Sciences Ltd PMN
Tranche A Common Share Purchase Warrants · derivative
|
2025-07-25 | Option exercise | 119,800 | $0.00 | |
|
Amorfix Life Sciences Ltd PMN
Common Shares, no par value
|
2025-07-25 | Option exercise | 119,800 | ||
|
Amorfix Life Sciences Ltd PMN
Common Shares, no par value
|
2025-07-25 | Option exercise | 119,800 | ||
|
Amorfix Life Sciences Ltd PMN
Common Shares, no par value
|
2025-07-25 | Option exercise | 119,800 | ||
|
Amorfix Life Sciences Ltd PMN
Tranche C Common Share Purchase Warrants · derivative
|
2025-07-25 | Option exercise | 119,800 | $0.00 | |
|
Amorfix Life Sciences Ltd PMN
Tranche B Common Share Purchase Warrants · derivative
|
2025-07-25 | Option exercise | 119,800 | $0.00 | |
|
Amorfix Life Sciences Ltd PMN
Common Shares, no par value
|
2024-07-31 | Buy | 465,116 | ||
|
Amorfix Life Sciences Ltd PMN
Tranche A Common Share Purchase Warrants · derivative
|
2024-07-31 | Buy | 465,116 | ||
|
Amorfix Life Sciences Ltd PMN
Series 2 Preferred Shares, no par value · derivative
|
2024-07-31 | Conversion | 500,000 | ||
|
Amorfix Life Sciences Ltd PMN
Tranche C Common Share Purchase Warrants · derivative
|
2024-07-31 | Buy | 465,116 | ||
|
Amorfix Life Sciences Ltd PMN
Tranche B Common Share Purchase Warrants · derivative
|
2024-07-31 | Buy | 465,116 | ||
|
Amorfix Life Sciences Ltd PMN
Common Shares, no par value
|
2024-07-31 | Conversion | 500,000 |